- Home
- SVV vs NVCR Comparison
SVV vs NVCR Comparison
Compare SVV & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SVV | NVCR |
|---|---|---|
| Founded | 1954 | 2000 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | SVV | NVCR |
|---|---|---|
| Price | $9.48 | $16.15 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | $13.67 | ★ $28.08 |
| AVG Volume (30 Days) | 1.3M | ★ 1.4M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 21.79 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,678,954,000.00 | $655,353,000.00 |
| Revenue This Year | $6.91 | $7.72 |
| Revenue Next Year | $7.80 | $6.74 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 9.19 | 8.28 |
| 52 Week Low | $6.91 | $9.82 |
| 52 Week High | $13.89 | $19.25 |
Technical Indicators
Market Signals| Indicator | SVV | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 68.78 | 45.67 |
| Support Level | $9.03 | $12.48 |
| Resistance Level | $9.98 | $18.80 |
| Average True Range (ATR) | 0.41 | 0.88 |
| MACD | 0.20 | -0.43 |
| Stochastic Oscillator | 99.43 | 22.59 |
Price Performance
Historical ComparisonAbout SVV Savers Value Village Inc.
Savers Value Village Inc is a for-profit thrift operator in the United States and Canada. It purchases second-hand textiles (i.e., clothing, bedding, and bath items), shoes, accessories, housewares, books, and other goods from its non-profit partners (NPPs), either directly from them or via on-site donations (OSDs) at Community Donation Centers at its stores. The company then processes, selects, prices, and sells these items in its stores.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.